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Abstract
Background: This two-part study examines primary care clinicians' chart documentation and
attitudes when confronted by a positive waiting room screen for intimate partner violence (IPV).
Methods:  Patients at community hospital-affiliated health centers completed a screening
questionnaire in waiting rooms that primary care providers (PCPs) were subsequently given at the
time of the visit. We first reviewed the medical records of patients who screened positive for IPV,
evaluating the presence and quality of documentation. Next we administered a survey to PCPs that
measured their knowledge, attitudes and practice regarding IPV.
Results: Seventy-two percent of charts contained some documentation of IPV, however only 10%
contained both a referral and safety plan. PCPs were more likely to refer patients (p < .05) who
screened positively for mood or anxiety disorders, disclosed that they feared for their safety or
were economically disadvantaged. Those that feared for their safety or endorsed mood or anxiety
disorders were more likely to have notation of a safety plan in their records. When surveyed,
81.6% of clinicians strongly agreed that it is their role to inquire about IPV, but only 68% expressed
confidence in their ability to manage it. In contrast, 93% expressed confidence in managing
depression. Sixty-seven percent identified time constraints as a barrier to care. Predictors of PCP
confidence in treating patients who have experienced IPV (p < .05) included hours of recent training
and clinical experience with IPV.
Conclusion: Mandatory waiting room screening for IPV does not result in high levels of referral
or safety planning by PCPs. Despite the implementation of a screening process, clinicians lack
confidence and time to address IPV in their patient populations suggesting that alternative methods
of training and supporting PCPs need to be developed.
Background
Intimate Partner Violence (IPV) is a major public health
problem in the U.S. Nearly one-quarter of all women and
7.4% of men have been physically and/or sexually abused
by an intimate partner in their adult lives [1]. Women are
more likely than men to experience IPV and to be injured
during an assault [1]. IPV is prevalent across geographic
settings, social classes and ethnic groups [2].
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Medical patients frequently have a history of IPV. In pri-
mary care practices, 5.5 to 14% of patients present with a
history of recent IPV (abuse occurring in the preceding 12
months), while reported lifetime prevalence in these same
settings ranges from 21 to 51% [3-5]. Women who have
experienced IPV have higher rates of chronic medical con-
ditions [6-8], and utilize more health care services [7-9].
Despite the high prevalence of IPV and its well-estab-
lished adverse health impact, clinicians often do not
assess their patients for IPV exposure [5,10,11]. Previous
work has addressed barriers to clinician assessment for
IPV. The barriers reported in the literature vary based on
practice type and location, but recurring common themes
include lack of time [12], fear of offending patients
[10,12], fear of retaliation by the partner [11], and lack of
confidence, training or inadequate resources [10,12].
Busy clinicians may simply forget to ask about IPV [10].
Despite these obstacles, most patients are willing to dis-
cuss the subject of partner violence with their medical care
providers and believe that clinicians can be of assistance
[13]. Abused women are even more likely than non-
abused women to endorse screening [14]. Notwithstand-
ing, universal screening for IPV remains controversial
[15,16].
While prior research has examined barriers to clinician-
initiated screening for IPV [10,12,17], less is known about
how clinicians respond when information about a
patient's IPV status is elicited for them. A better under-
standing of what patient or clinician characteristics drive
an observed response to a positive IPV screen could
inform ongoing efforts to train providers or even redirect
resources in clinical settings. To address these issues, we
conducted a two-part study to assess primary care pro-
vider (PCP) response to a positive screen for IPV. Using
data collected in a mental health screening program at a
community hospital and its affiliated health centers, we
first conducted a medical record review of patients who
had screened positive for IPV. Following the chart review,
we surveyed PCPs to explore their attitudes and practices
around intervention for patients who have experienced
IPV.
Methods
The study took place at an urban network of publicly
owned community hospitals and health centers that
serves an ethnically diverse population of poor and mid-
dle-income patients. In 1997, the Department of Medi-
cine developed a program to train family practitioners,
internists and primary care nurse practitioners to identify
and treat patients who were victims of IPV. This program
was linked to a citywide program administered by the
local Department of Public Health. The training initiative
included publication of a manual for PCPs and a series of
three Grand Rounds presentations in 1997.
In the spring of 1998, the Department began routine
screening for mental health (MH) and IPV at most of its
primary care sites. A series of three IPV screening ques-
tions were appended to the MH screen which was adapted
from the PRIME-MD [18]. These questions were answered
in a variable time period, usually in the waiting room,
prior to the encounter with the PCP. The questions were:
1. Is violence/abuse a concern in your personal relation-
ships (past or present)?
2. Has anyone hit, pushed, slapped or threatened you in
the past year?
Checklist of Clinician Responses Figure 1
Checklist of Clinician Responses.BMC Family Practice 2005, 6:48 http://www.biomedcentral.com/1471-2296/6/48
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3. Is anyone in your personal life causing you to be fearful
for your safety?
Question 1 queries lifetime abuse while question 2 asks
about incidents occurring in the preceding 12 months.
Clinical encounters were not delayed if a patient did not
have time to complete the screen. The instrument was ini-
tially only available in English; in the second year of the
study it was translated into Spanish, Portuguese and Hai-
tian Creole. Interpreters assisted patients with completion
of the questions when necessary. During the patient visit,
the PCP, a nurse practitioner (NP) or physician was asked
to review the mental health screen along with the
responses to the IPV questions. After evaluating the
patient, the provider was directed to document an assess-
ment and plan on a separate response form, and the clinic
staff faxed this form back to the Quality Management
department. The response form contained a checklist
intended to facilitate documentation (Figure 1). A data-
base of screen-positive patients over the two-year period
1998–2000 was compiled.
Chart review
In the first segment of the study, we reviewed the charts of
patients who had screened positive for IPV in order to
determine the nature and extent of clinician documenta-
tion following the positive IPV screen. Study standards for
ideal chart documentation were derived from national
consensus and state medical association guidelines that
recommend detailed documentation of the circumstances
of the abuse and of subsequent assessment, intervention
and referral [2,19]. Thorough medical record documenta-
tion may provide important support to victims in legal
settings [19]. Documentation in medical records also
facilitates continuity of care between visits and among cli-
nicians.
Four chart reviewers (two internal medicine physicians, a
medical student and a dentist) abstracted data. We
checked for inter-observer variability by having reviewers
independently abstract sample charts: 90% agreement
was demonstrated. As part of the review, we collected
demographic data for both patient and provider charac-
teristics. In addition, charts were examined for the follow-
ing: any written acknowledgement of the positive IPV
screen (whether on the faxed back response form or in the
progress note), documentation of referral, safety planning
and detailed descriptive circumstances of the abuse. Data
on co-morbid psychiatric conditions were collected at the
time of IPV screening and then extracted for our analysis
from the same database compiled by Quality Manage-
ment.
We next performed basic summary statistics analyzing
patient and clinician demographic variables, psychiatric
co-morbidities and chart review outcomes by response on
each of the three screening questions to examine how
these characteristics differed by category of IPV or concern
for safety. Logistic regression analysis was then carried out
to estimate two separate models examining which varia-
bles predict referral and safety planning for both lifetime
and 12-month IPV.
Clinician survey
In the second phase of the project, we designed a provider
survey to characterize PCP beliefs and practices, in order
to better understand the findings from the initial chart
review (see Additional file 1). One of the goals of this por-
tion of the study was to measure the impact our locally
designed departmental training had on clinicians' prac-
tice, so we chose to develop our own instrument rather
than use an existing one. We referenced previous work
that had queried clinicians' knowledge, attitudes and
practice regarding IPV in clinical practice [20-22].
Informed by prior studies, we measured our clinicians'
perception of self-efficacy and sense of their role in
addressing IPV [20,21]. We queried clinicians about the
barriers to addressing IPV reported in previous studies
[10-12,17]. Additionally drawing upon prior work, we
inquired about clinicians' screening practices and their
estimate of IPV prevalence among their patient panels
[10,11,21]. Since we hypothesized that clinician confi-
dence was an important factor in addressing IPV in prac-
tice, we included several items directly comparing
management of IPV to other common medical and behav-
ioral health conditions; a similar comparison has been
made in other survey studies for adverse health behaviors
[21]. Our survey also measured the frequency with which
clinicians accessed existing hospital services when work-
ing with patients who have experienced IPV. We collected
demographic data from clinicians including gender, age,
and year of graduation from professional school. We also
Observed Chart Documentation of IPV (N = 90) Figure 2
Observed Chart Documentation of IPV (N = 90).
Screen noted, no
response
19%
No
Documentation
of screen
28%
Screen noted,
referral and
safety plan
10%
Screen noted,
patient referred
43%BMC Family Practice 2005, 6:48 http://www.biomedcentral.com/1471-2296/6/48
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queried self-report of attendance at the original training
Grand Rounds and the number of hours spent training
since 1997. The survey contained scales measuring atti-
tudes toward IPV diagnosis, perceived barriers to caring
for victims, and types of intervention and resources
accessed.
Between April and July of 2002, the survey was distributed
and returned by interoffice mail and at a department
meeting to clinicians practicing adult primary care at the
same clinical sites that participated in the screening pro-
gram. This sample was deemed representative of the clini-
cians caring for the screen-positive patients in 1998–
2000. We used multivariate regression analyses to esti-
mate predictors of PCP confidence with IPV.
The hospital institutional review board (IRB) approved
the two-part study. Analyses were conducted using STATA
8.0 Statistical software (Stata Corp., College Station, TX).
Results
Chart review
During the two-year period 1998–2000, 4.9% (115/
2341) of patients at 11 different neighborhood health
centers (NHC) and primary care clinics screened positive
for IPV. Of the screen-positive patients, charts of 95 (83%)
were located for review. Of the 95 charts reviewed, five
contained documentation of abuse that was not partner-
inflicted (for example, political violence in foreign coun-
tries). These five patients were excluded from further anal-
yses. The final number of charts eligible for review was 90.
Of the ninety IPV+ charts reviewed, 72% contained some
clinician documentation of the positive screen; however,
nearly one-third of the charts (28%) reviewed contained
no acknowledgement of the positive IPV screen. Only
nine charts (10%) contained a detailed history of the
abuse along with documentation of referral and safety
planning (Figure 2).
Seventy-two percent of the IPV+ patients were female and
the mean age was 34 years (Table 1). Female patients
comprised the majority of patients screening positive for
both lifetime and 12 month IPV. The majority of IPV+
patients were white but more non-white patients
endorsed a 12-month history of IPV (Table 1). Of the
encounters reviewed, 64% were charted by physicians. All
of the positive screens were from questionnaires com-
pleted in English. The majority of patients who screened
positive for IPV were on Medicaid or Free Care (by defini-
tion these patients are of low income). More than three-
quarters of the patients who answered affirmatively on the
question querying fear for safety were female and of low
income. The majority of patients screening positive for
lifetime and 12-month IPV also screened positive for co-
morbid mood and anxiety disorders. While a minority
(23%) endorsed an eating disorder, more patients with
12-month IPV reported this condition.
Table 1: Covariates and IPV.
Covariate Total N (%) Lifetime IPV
 N = 77
12 month IPV
 N = 30
Fear for Safety
 N = 9
Ethnicity
White = REF
51/90 (57) 47/74 (64) 13/29 (45) 4/8 (50)
Patient Gender
Female = REF
65/90 (72) 56/77 (73) 21/30 (70) 7/9 (78)
Age (mean years) 34 34 33 33
Insurance
Medicaid/Free Care = REF
69/90 (77) 60/74 (81) 21/29 (72) 8/9 (89)
Clinician Characteristics
Gender
Female = REF
65/90 (72) 58/77 (75) 18/30 (60) 8/9 (89)
Clinician Type
Physician = REF
58/90 (64) 51/77 (66) 19/29 (66) 4/9 (44)
Psych Screen
Eating DO 21/90 (23) 17/74 (10) 10/29 (34) 4/9 (44)
Mood 47/90 (52) 39/74 (53) 18/29 (62) 6/9 (67)
Anxiety 59/90 (66) 50/74 (68) 21/29 (72) 8/9 (89)
Chart Review Outcomes
Referral 44/90 (49) 40/76 (53) 14/30 (47) 7/9 (78)
Safety Plan 13/90 (14) 12/77 (16) 7/30 (23) 5/9 (56)BMC Family Practice 2005, 6:48 http://www.biomedcentral.com/1471-2296/6/48
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Data on the unavailable charts (n = 20) was abstracted
from the hospital electronic medical record (EMR) sys-
tem. The patients whose charts were unavailable for
review appeared comparable to those reviewed: their
mean age was 35 years and 71% were female. However,
71% of the patients whose charts were missing were
described as white by the hospital EMR. Medical record
number transcription error and misfiling were the most
common reasons for charts to be unavailable for review.
All of the sites had unavailable records, no clustering of
missing charts by site was observed.
The determinants of referral and of safety planning are
shown in Tables 2 and 3, respectively. We found that cli-
nicians were more likely to refer patients (p < .05) who
screened positively for mood or anxiety disorders or who
had low income (Medicaid or Free Care insurance types),
although the latter was not significant when adjusted for
potential confounders (Table 2). Female clinicians' charts
exhibited a higher proportion of documented referrals
than those of their male counterparts, however this find-
ing did not reach statistical significance. While nurse prac-
titioners' charts had higher rates of documented referral
than those of physicians, this difference also failed to
achieve statistical significance.
The results for the Safety Planning model showed a differ-
ent pattern (Table 3). Patient endorsement of question 3,
expressing fear for safety, was associated with safety plan-
ning documentation in charts. Only female patients'
charts contained any documentation of safety planning.
The site, or NHC, where screening took place was signifi-
cant in both univariate and multivariate models, suggest-
ing that safety planning practices may be site-specific. As
with referral documentation, screening for the psychiatric
co-morbidities of mood or anxiety appear to result in
higher rates of safety planning.
Survey
Seventy clinicians identified as eligible were surveyed. The
overall response rate was 84%, 88% (40/45) for physi-
cians and 76% (19/25) for nurse practitioners. The major-
ity of respondents were physicians (57%). By self-report,
nurse practitioners saw a mean of 10 cases annually while
physicians reported 6 (p-value .057, 2-sample T-test).
The majority (81.6%) of PCPs strongly agreed that it is
their role to inquire about IPV in the primary care setting.
However, only 68% agreed that they were confident in
their ability to diagnose and manage patients who had
experienced IPV. By contrast, these clinicians reported
high degrees of confidence with other medical and behav-
Table 2: Predictors of Referral Documentation in Medical Records.
Covariate Univariate O.R. 
(95% C.I.)
Lifetime Multivariate O.R. 
(95% C.I.)
12-month Multivariate O.R. 
(95% C.I.)
Screen for IPV
Lifetime IPV "Is violence/abuse a concern in your 
personal relationships? (past or present)"
2.5 (0.70–8.8) 6.93 (1.09–43.84) ____
12-month IPV "Has anyone hit, pushed, slapped or 
threatened you in the past year?"
0.85 (0.35–2.0) ____ 0.35 (0.94–1.30)
Fear for Safety "Is anyone in your personal life 
causing you to be fearful for your safety?"
4.10 (0.80–21) 2.35 (0.33–16.73) 6.31 (0.72–55.49)
Patient Demographics
Age 0.980 (0.94–1.02) 0.99 (0.93–1.04) 0.99 (0.94–1.05)
Ethnicity 1.37 (0.57–2.29) 2.41 (0.76–7.66) 2.16 (0.71–6.60)
Gender
Female = REF
1.35 (0.53–3.43) 0.49 (0.12–2.06) 0.54 (0.13–2.27)
Insurance
Free Care/Medicaid = REF
4.70 (1.40–15.80) 2.88 (0.74–11.07) 2.83 (0.73–10.93)
Clinician Characteristics
Female 2.15 (0.83–5.57) 2.53 (0.59–10.87) 2.39 (0.54–10.61)
Type
Physician = REF
0.56 (.23–1.37) 0.43 (0.13–1.45) 0.51 (0.16–1.62)
Site 0.97 (.84–1.12) 0.87 (0.70–1.07) 0.89 (0.73–1.10)
Screen for Co-morbid Psychiatric Conditions
Eating Disorder .88 (.33–2.36) ________ _______
Mood 2.59 (1.08–6.20) 3.61 (1.20–10.88) 3.64 (1.24–10.7)
Anxiety 2.99 (1.15–7.73) 4.25 (1.20–15.10) 4.02 (1.18–13.73)BMC Family Practice 2005, 6:48 http://www.biomedcentral.com/1471-2296/6/48
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ioral health conditions: 90% expressed comfort treating
Chronic Obstructive Pulmonary Disease, 93% were com-
fortable with depression and 83% with substance abuse.
A time constraint was the practice barrier endorsed most
frequently in our study (67%).
The only factors significantly associated with provider
confidence in IPV management were the number of hours
of IPV training reported since 1997 and self report of fre-
quency of treating patients who have experienced IPV.
These two variables remained significant when adjusted
for demographics and year of professional school gradua-
tion (Table 4).
Discussion
While prior studies in the primary care setting have
focused on practice and frequency of provider-generated
screening for IPV, our study evaluated an intervention that
bypassed potential clinician barriers to initiating screen-
ing with use of a waiting room questionnaire. The finding
that 4.9% of patients screened positive for IPV is consist-
ent with other reports from primary care ambulatory set-
tings [3-5]. However, the high proportion of males
screening positive (31%) exceeds estimates in other stud-
ies. It is possible that some of these represent false posi-
tives. Review of chart narratives suggested that some of
these male patients might actually have been batterers.
Further study is needed to understand if battering behav-
ior can be reliably detected in the primary care setting and
whether detection would be efficacious.
Table 3: Predictors of Safety Planning Documentation in Medical Records.
Covariate Univariate O.R. 
(95% C.I.)
Lifetime Multivariate O.R. 
(95% C.I.)
12-month Multivariate O.R. 
(95% C.I.)
Screen for IPV
Lifetime IPV "Is violence/abuse a concern in your 
personal relationships? (past or present)"
2.22 (.26–18.66) 1.14 (.05–23.72) ____
12-month IPV "Has anyone hit, pushed, slapped or 
threatened you in the past year?"
2.74 (.83–9.05) ____ 5.66 (0.79–40.52)
Fear for Safety "Is anyone in your personal life 
causing you to be fearful for your safety?"
11.40 (2.54–51.31) ____ ____
Patient Demographics
Age 1.00 (.95–1.06) 0.98 (.92–1.05) 0.98 (.91–1.04)
Ethnicity 0.93 (.28–1.06) 1.30 (.24–7.18) 1.17 (.21–6.71)
Gender† ____ ____ ____
Insurance
Free Care/Medicaid = REF
0.85 (0.21–3.49) 2.61 (.23–30.20) 2.81 (.20–38.76)
Clinician Characteristics
Female 2.34 (.48–11.4) 0.25 (.01–5.90) 0.27 (.01–7.68)
Type
Physician = REF
1.24 (0.35–4.40) 4.65 (.74–29.30) 5.28 (.74–37.38)
Site 1.32 (1.07–1.63) 2.18 (1.23–3.86) 2.44 (1.18–5.08)
Screen for Co-morbid Psychiatric Conditions
Eating Disorder 0.93 (0.23–3.77) 0.20 (.02–2.47) .07 (.003–1.78)
Mood 0.69 (.21–2.25) 0.08 (.01–.88) .03 (.001–.71)
Anxiety 1.70 (.43–6.74) 15.03 (1.56–143.89) 16.45 (1.31–206.42)
†Only female patients' chart contained documentation of safety planning.
Table 4: Determinants of provider confidence in IPV Management (Survey Data), Multivariate Linear Regression.
Variable Unadjusted β (p-value) Adjusted β (p-value)
Clinician Age -0.24 (.124) -0.26 (.290)
Clinician Type REF = MD 0.45 (.102) 0.22 (.521)
Years since professional school graduation -0.02 (.241) .004 (.871)
Provider gender REF = female -0.21 (0.423) -0.38 (.279)
Number hours trained since 1997 REF =< 3 -0.37 (0.029) -0.43 (0.025)
Clinical experience with IPV 0.47 (<.001) 0.29 (0.042)BMC Family Practice 2005, 6:48 http://www.biomedcentral.com/1471-2296/6/48
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While the majority of charts (72%) contained some docu-
mentation of the positive screen, nearly one-third of
charts contained no medical record notation of the posi-
tive screen for IPV. This finding suggests that mandated
waiting room screening is not sufficient to insure proper
documentation and assessment by clinicians. Of the
charts that did contain written acknowledgement of the
positive screen, only 10% demonstrated adherence to the
most complete level of documentation. While prior
research has shown that medical records accurately reflect
clinical reasoning [23], clinician behavior, particularly in
sensitive matters, may not be fully represented by the
medical record. At best, documentation is likely a proxy
measure of clinicians' responses to a positive IPV screen. It
is possible that appropriate care was, nevertheless, being
delivered. In another study of an educational intervention
in urban neighborhood health centers, documentation in
the medical record did not change despite increases in the
rate of screening and referral [24].
Unmeasured patient factors, such as degree of readiness to
change, remain a possible explanation for the observed
low rates of clinician documentation. This may be partic-
ularly true for documentation of referral and safety plan-
ning. Research applying the transtheoretical model of
behavior change to abused women demonstrates that
acknowledging that a relationship is abusive and accept-
ing help often occur through a process of change [25,26].
It is possible that some of the patients identified through
the screening program were not yet ready to engage in
such a discussion with their clinicians or accept referrals.
This phenomenon may underlie the lack of chart docu-
mentation. Possibly patient reluctance to have IPV docu-
mented may also have contributed to the low rates. Still,
it is reasonable to expect that clinicians would, at a mini-
mum, document the positive screen, even if the patient
did not accept a referral or engage in a conversation about
safety planning. In the earliest stage of precontemplation,
research supports documenting suspicion about IPV [25].
Given the potential pitfalls of relying on medical record
documentation, some investigators have recommended
use of patient exit interviews as a more accurate measure
of interventions for partner violence [22]. Yet for victims
of IPV, medical record documentation is critical to pro-
tecting the patient's interests and safety [19] and thorough
medical record documentation of IPV is recommended in
national consensus guidelines [2].
When clinicians do document, our data suggests that cer-
tain patient factors – anxiety, mood, poverty and fear for
safety – predict documentation by clinicians. Based on
these findings, further study could determine whether
questions that communicate a patient's perception of risk
to clinicians result in improved documentation. Poverty
may be a facilitating factor, as these patients had better
insurance coverage for counseling than some privately
insured patients did. Only female patients received safety
planning. This finding may reflect a true subset of patients
at high risk for violence and may also support the possi-
bility that a proportion of the male patients screened
falsely positive and were not at-risk victims. Gender bias
on the part of clinicians is another potential explanation
for this finding.
While both recent and lifetime IPV have important impli-
cations for health status, detection of recent IPV brings
with it potential implications for a patient's safety. In this
study, the 12-month IPV question was not predictive of
referral documentation while the lifetime query was. It is
unclear whether this finding relates to provider discom-
fort with the topic or deficiencies in training, both of
which should be addressed in future work.
The provider survey results suggest that lack of confidence
and experience with IPV, along with time constraints, may
drive the observed variations in clinician approach to
patients who have experienced IPV. Conversely, the
majority of clinicians expressed comfort in their ability to
manage depression and substance abuse. This difference
is notable since these conditions, like IPV, have been con-
sidered sensitive and of a private nature in the past and
might still carry a stigma for some patients.
Limitations
Our study has a number of limitations. The screening
questions were not validated and generated false positive
screens for IPV. The questions were narrow in scope and
did not address the dimensions of emotional or sexual
abuse, possibly failing to identify an important segment
of the target population, and likely resulting in an under-
estimate of the true prevalence of IPV in our population.
This may also impact the external validity of the study.
Our sample was a convenience sample and we do not
know the total number of patients who received the ques-
tionnaires in waiting rooms; the only screens counted
were those returned by the clinical sites. Distributing the
screening questions in the waiting room may have
resulted in false negative responses, as some of the
patients may have been accompanied by a battering part-
ner or may have had concerns for confidentiality. The lack
of positive screens on any instrument translated into
another language raises concerns about literacy and cul-
tural barriers to written disclosure of sensitive informa-
tion. Data on gender preference was often not available in
charts rendering us unable to determine whether a per-
centage of the males screening positive were men who
have sex with men. In addition, PCP survey responses may
have been biased to comply with the department's
strongly stated position on the importance of IPV recogni-BMC Family Practice 2005, 6:48 http://www.biomedcentral.com/1471-2296/6/48
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tion and intervention. These responses may not be gener-
alizeable to other departments that lack such a clear
mandate. The urban setting of the study may also limit the
generalizeability of our results to institutions in non-
urban areas. Finally, our sample size was small, limiting
the ability to detect statistically significant relationships
among the variables and producing wide confidence
intervals for some of the estimates.
Conclusion
When prompted by a positive IPV screen, clinicians fre-
quently address this issue; however their chart documen-
tation (and possibly their approach) is inadequate. They
express less confidence in their ability to address IPV than
other medical conditions that carry a similar social
stigma. Why are clinicians so much more confident in
managing other potentially stigmatizing conditions, such
as substance abuse? One possible explanation is a shift in
professional mores: conditions such as this one have
evolved from being considered private, personal afflic-
tions to diseases with a clear health impact. Only after a
shift in the way these conditions were regarded did strate-
gies for effective training and proven intervention evolve.
It is only in the last decade that IPV has been recognized
as a significant medical concern [27]. Alternative
approaches are necessary to assist clinicians in adequately
addressing IPV in office practice; as the results of this
study demonstrate, waiting room screening alone is not
sufficient. Potential areas for future investigation include
the development and evaluation of experiential educa-
tional methods for clinicians and identification of the
optimum frequency for retraining PCPs in proper docu-
mentation, referral and safety planning. Electronic medi-
cal record prompts may also aid busy clinicians and
provide seamless, legible documentation of IPV. It is
incumbent upon primary care clinicians to improve the
identification and quality of care for the large number of
patients they routinely see who experience partner vio-
lence.
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